We are live on !
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
Turnover
20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$233K
(-0.23%)
Cap. Flow
+$2.63M
Cap. Flow % of AUM
Cap. Flow %
2.63%
Top 10 Holdings %
Top 10 Hldgs %
20.23%
Holding
305
New
56
Increased
128
Reduced
51
Closed
53
Avg Time Held
1
year
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Builders FirstSource
BLDR
|
+$1.07M |
| 2 |
Pennant Park Investment Corp
PNNT
|
+$830K |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$749K |
| 4 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$725K |
| 5 |
Xometry
XMTR
|
+$664K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$2.48M |
| 2 |
Alpine Income Property Trust
PINE
|
+$1.88M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$939K |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$812K |
| 5 |
Exact Sciences
EXAS
|
+$802K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.59% |
| 2 | Miscellaneous | 18.8% |
| 3 | Industrials | 10.06% |
| 4 | Real Estate | 8.71% |
| 5 | Technology | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Oruka Therapeutics
ORKA
$4.76B
| $564K | 0.56% |
11,506
+626
| +6% | +$21.8K |
2024 Q4
5 quarters
|
|
52
Kratos Defense & Security Solutions
KTOS
$7.59B
| $564K | 0.56% |
8,000
+500
| +7% | +$47.9K |
2025 Q4
1 quarter
|
|
53
Graphic Packaging
GPK
$2.54B
| $547K | 0.55% |
55,000
| – | – |
2024 Q4
5 quarters
|
|
54
Richtech Robotics
RR
$290M
| $522K | 0.52% |
250,000
| – | – |
2025 Q4
1 quarter
|
|
55
Kodiak AI
KDK
$271M
| $520K | 0.52% |
75,000
| – | – |
2025 Q4
1 quarter
|
|
56
SoundHound AI
SOUN
$2.1B
| $515K | 0.51% |
75,000
+12,500
| +20% | +$108K |
2023 Q2
11 quarters
|
|
57
AT&T
T
$161B
| $511K | 0.51% |
17,619
+6,138
| +53% | +$164K |
2025 Q4
1 quarter
|
|
|
58
Xometry
XMTR
$5.21B
| $510K | 0.51% |
+12,500
| New | +$664K |
2026 Q1
0 quarters
|
|
59
BioNTech
BNTX
$22B
| $499K | 0.5% |
5,616
+305
| +6% | +$31.3K |
2024 Q4
5 quarters
|
|
60
Ondas Inc
ONDS
$3.52B
| $497K | 0.5% |
+55,000
| New | +$598K |
2026 Q1
0 quarters
|
|
61
Krystal Biotech
KRYS
$9.37B
| $495K | 0.49% |
1,918
+105
| +6% | +$27.9K |
2024 Q4
5 quarters
|
|
62
Edgewise Therapeutics
EWTX
$4.04B
| $492K | 0.49% |
15,615
+912
| +6% | +$26.3K |
2024 Q4
5 quarters
|
|
63
Invesco Senior Loan ETF
BKLN
$6.27B
| $485K | 0.48% |
23,752
+3,500
| +17% | +$72.3K |
2023 Q1
12 quarters
|
|
64
Microbot Medical
MBOT
$63.8M
| $482K | 0.48% |
200,000
| – | – |
2020 Q2
23 quarters
|
|
65
DELISTED
Nuvalent
NUVL
| $477K | 0.48% |
4,657
+253
| +6% | +$25.8K |
2025 Q4
1 quarter
|
|
66
Agios Pharmaceuticals
AGIO
$1.87B
| $473K | 0.47% |
13,971
+830
| +6% | +$23.5K |
2024 Q4
5 quarters
|
|
67
NewAmsterdam Pharma
NAMS
$2.37B
| $469K | 0.47% |
14,656
+925
| +7% | +$30.1K |
2025 Q4
1 quarter
|
|
68
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.19B
| $466K | 0.47% |
5,093
+415
| +9% | +$38.7K |
2023 Q2
11 quarters
|
|
69
Manhattan Associates
MANH
$13B
| $466K | 0.47% |
+3,500
| New | +$524K |
2026 Q1
0 quarters
|
|
70
iShares JPMorgan EM High Yield Bond ETF
EMHY
$577M
| $465K | 0.46% |
11,810
+1,313
| +13% | +$53K |
2023 Q1
12 quarters
|
|
71
MeiraGTx Holdings
MGTX
$891M
| $465K | 0.46% |
53,694
+25,198
| +88% | +$191K |
2025 Q4
1 quarter
|
|
72
Sidus Space
SIDU
$120M
| $464K | 0.46% |
+200,000
| New | +$545K |
2026 Q1
0 quarters
|
|
73
Invesco S&P 500 BuyWrite ETF
PBP
$389M
| $463K | 0.46% |
21,069
+2,528
| +14% | +$57.3K |
2023 Q1
12 quarters
|
|
74
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.1B
| $463K | 0.46% |
4,931
+551
| +13% | +$52.9K |
2023 Q1
12 quarters
|
|
|
WSR
75
DELISTED
Whitestone REIT
WSR
| $460K | 0.46% |
28,490
-1,510
| -5% | -$22.7K |
2024 Q4
5 quarters
|
|
Similar funds
CWM
MCM
WUW
AGAM
ERWM
KWM
KCIA
BWF
AlphaCentric Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, AlphaCentric Advisors held 305 positions worth $100M, down 0.23% from $100M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
AlphaCentric Advisors's Q1 2026 filing shows 56 new, 128 increased, 51 reduced and 53 closed positions. Its largest new stake was Builders FirstSource: 10,000 shares worth $823K. The largest sale was iShares MBS ETF, an estimated $2.48M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 41% a quarter earlier, followed by Miscellaneous and Industrials.
- AlphaCentric Advisors's largest Q1 2026 buy was Builders FirstSource: 10,000 shares worth $823K.
- AlphaCentric Advisors added most to iShares Russell 1000 Value ETF in Q1 2026, an estimated $749K increase.
- AlphaCentric Advisors's biggest Q1 2026 reduction was AMREP Corp, cutting an estimated $486K.
- AlphaCentric Advisors fully exited iShares MBS ETF in Q1 2026, selling an estimated $2.48M.
- AlphaCentric Advisors's ten largest holdings make up 20% of its $100M portfolio in Q1 2026.
- AlphaCentric Advisors opened 56 new positions and closed 53 in Q1 2026.
- AlphaCentric Advisors's portfolio value fell 0.23% quarter-over-quarter to $100M.
Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.